The main substance in Covis Pharma’s premature birth drug Makena — a synthetic hormone known as 17α-hydroxyprogesterone caproate (17-OHPC) — has been linked with an increased risk of cancer in…
Ten of the nation’s highest-ranked hospitals charge health insurance companies and patients paying out of pocket far more than the amount Medicare pays for several infused drugs, according to a…
Pfizer and BioNTech are seeking an amended Emergency Use Authorization (EUA) from the FDA allowing their COVID-19 vaccine booster for general use in adults over age 18. Source: Drug Industry…
Biogen is investigating the death of a 75-year-old patient from cerebral edema that was possibly related to the antiamyloid antibody Aduhelm. Source: Drug Industry Daily
The FDA has issued nearly 50 draft product-specific guidances (PSG) meant to help accelerate generic drug development by industry sponsors. Source: Drug Industry Daily
In a stunning decision, Oklahoma’s supreme court has reversed a $465 million verdict against Johnson & Johnson (J&J), regarding allegations the drugmaker contributed to the state’s public health crisis by…
Bristol Myers Squibb (BMS) unveiled positive interim results from its phase 3 CheckMate trial, showing that Opdivo (nivolumab) plus chemotherapy significantly improved event-free survival in patients with resectable IB-IIIA nonsmall-cell…
GlaxoSmithKline’s (GSK) daprodustat increased or maintained hemoglobin levels in patients with anemia due to chronic kidney disease (CKD) across five phase 3 studies, says a new analysis. Source: Drug Industry…
Liquidia has grabbed tentative FDA approval for Yutrepia, the first inhalation powder form of treprostinil, a vasodilator used in other forms to treat pulmonary hypertension. Source: Drug Industry Daily
A single dose of Regeneron’s COVID-19 antibody cocktail, REGEN-COV, slashed the risk of contracting the coronavirus by 81.6 percent up to eight months after treatment in a phase 3 trial.…